This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • AM-101 in the Treatment of Acute Tinnitus 3 (TACTT...
Clinical trial

AM-101 in the Treatment of Acute Tinnitus 3 (TACTT3)

Read time: 1 mins
Last updated:14th Jan 2014

The purpose of this research study is to test the safety and effectiveness of the study drug, AM-101. AM-101 is tested for the treatment of tinnitus that started as the result of an injury to the inner ear or due to middle ear inflammation (otitis media). Subjects with tinnitus can take part in the study, if their tinnitus started within the last 3 months or within the last 4 to 12 months.

Category Value
Study start date 2014-01-14

View full details